Breaking News

Kadmon Acquires Three Rivers Pharma

Kadmon Pharmaceuticals has acquired Three Rivers Pharmaceuticals, a privately held specialty pharmaceutical company based in Warrendale, PA.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kadmon Pharmaceuticals has acquired Three Rivers Pharmaceuticals, a privately held specialty pharmaceutical company based in Warrendale, PA. Three Rivers adds commercial and operational aspects to Kadmon’s business. Terms of the agreement were not disclosed. Three Rivers markets several products for hepatitis C, including Infergen (Consensus Interferon), Ribasphere (ribavirin, USP) and RibaPak (ribavirin). The company also markets Amphotec (Amphotericin B Cholesteryl Sulfate) for the treatmen...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters